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We have used systematic mutational analysis to iden-
tify signals in the 166-residue murine cation-independ-
ent mannose 6-phosphate/insulin-like growth factor II
receptor cytoplasmic domain required for efficient sort-
ing of lysosomal enzymes. Alanine cluster mutagenesis
on all conserved residues apart from the endocytosis
signal demonstrates that the major sorting determinant
is a conserved casein kinase II site followed by a
dileucine motif (157DDSDEDLL164). Small deletions or
additions outside this region have severe to mild effects,
indicating that context is important. Single residue mu-
tagenesis indicates that cycles of serine phosphoryla-
tion/dephosphorylation are not obligatory for sorting.
In addition, the two leucine residues and four of the five
negatively charged residues can readily tolerate con-
servative substitutions. In contrast, aspartate 160 could
not tolerate isoelectric or isosteric substitutions, impli-
cating it as a critical component of the sorting signal.
An important question in cell biology is how itinerant pro-
teins are properly routed between different intracellular com-
partments. One particularly interesting example is the cation-
independent mannose 6-phosphate/insulin-like growth factor
II receptor (M6P/IGF2R),1 which mediates targeting of lysoso-
mal enzymes by two distinct pathways (reviewed in Refs. 1 and
2). In one pathway, the receptor functions in endocytosis of
extracellular ligands. In the other, the receptor functions in the
direct intracellular targeting of newly synthesized lysosomal
enzymes (“sorting”). There are multiple molecular events that
occur in each transport pathway. Like many other endocytic
receptors, M6P/IGF2Rs at the cell surface bind ligands, cluster
into clathrin-coated transport vesicles, and travel to an acidic
prelysosomal compartment. However, unlike most other recep-
tors, in the intracellular targeting pathway, M6P/IGF2Rs in
the Golgi apparatus bind newly synthesized mannose 6-phos-
phorylated lysosomal enzymes, cluster into clathrin-coated
transport vesicles, and travel to an acidic prelysosomal com-
partment, where the endocytic and intracellular targeting
pathways converge. Here, the low pH promotes dissociation of
the receptor-ligand complex, and the free receptors recycle back
to the plasma membrane or Golgi apparatus to function in
additional rounds of targeting.
As a step toward understanding the biochemical mecha-
nisms underlying these processes, we are characterizing the
determinants on the M6P/IGF2R important for intracellular
trafficking. The mature murine receptor has an amino-termi-
nal 2270-residue extracytoplasmic domain, a single 23-residue
membrane-spanning region, and a 166-residue carboxyl-termi-
nal cytoplasmic domain. While some targeting information
may reside in the extracytoplasmic region (3, 4), the cytoplas-
mic domain contains determinants required for both endocyto-
sis and sorting. Like many other endocytic receptors, rapid
internalization of the M6P/IGF2R requires a tyrosine-based
motif. This determinant is located in the first 30 residues of the
cytoplasmic domain and has been extensively characterized
(5–7). In contrast, the determinants required for sorting are
less well understood, but at least in part require residues
located in the C-terminal region of the cytoplasmic domain
(5, 8, 9).
In a previous study (8), we found that the cytoplasmic sorting
signals are conserved among bovine, human, and murine M6P/
IGF2Rs, and a consensus casein kinase II site followed by two
leucines near the C terminus is important for sorting. However,
the cytoplasmic domain contains multiple other conserved se-
quences that may be important, including a second consensus
casein kinase II site followed by valine and leucine. In this
study, we have systematically analyzed the function of the
conserved residues of the M6P/IGF2R and extensively charac-
terized the key sorting signal.
EXPERIMENTAL PROCEDURES
Materials—Enzymes used in molecular cloning were obtained from
New England Biolabs Inc., Life Technologies, Inc., or Stratagene. Ge-
neticin (G418) was obtained from Life Technologies, Inc. Na125I (NEZ-
033A; ;17 Ci/mg) was from DuPont NEN. Monoclonal antibodies
DM32g and DM86f7, which recognize different epitopes on the extra-
cellular domain of the bovine M6P/IGF2R, were generous gifts from Dr.
D. Messner (University of Rochester Medical School). Fetal bovine
serum (FBS) was obtained from Hyclone Laboratories and was heat-
inactivated prior to use. M6P/IGF2R-depleted FBS was prepared as
described previously (10). The mouse L(Rec2) cell line 13.2.1 overpro-
ducing human b-glucuronidase was kindly provided by Dr. W. Sly (St.
Louis University), and the phosphorylated form was purified as de-
scribed (6). Antibodies and b-glucuronidase were iodinated using solu-
ble lactoperoxidase as described (11).
Cell Culture—Hepes-buffered DMEM/Ham’s F-12 medium (DMEM/
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F-12) containing bicarbonate, without phenol red, was made from
DMEM/Ham’s F-12 base (Sigma D9785) and other cell culture-grade
biochemicals (Sigma) according to the supplier’s directions.
L(CIMPR2)D9, a clonal derivative of a mouse M6P/IGF2R-deficient L
cell line (12), has been described previously (8). Cells were routinely
grown in DMEM/F-12 and 10% FBS at 37 °C in 5% humidified CO2.
Transfected cells were maintained in the presence of 350 mg/ml (active
concentration) G418. When assaying for function of the receptor in
lysosomal enzyme targeting, fresh glutamine was added to glutamine-
deficient medium to minimize production of ammonia that may have
lysosomotropic effects. For surface distribution and internalization as-
says, frozen stocks were thawed and expanded, and cells were plated at
the same cell numbers and grown to confluence prior to assay.
DNA Constructs—The portions of the murine M6P/IGF2R used in
truncation mutants D4, D13, D17, and D53 were synthesized using the
unidirectional nested deletion strategy described previously (8). The
other constructs were synthesized by oligonucleotide-directed (13) or
polymerase chain reaction-mediated (14) mutagenesis. Sequences of the
oligonucleotide primers are compiled in Ref. 15. The template was the
previously described fragment of the murine M6P/IGF2R cytoplasmic
domain that contained 20 nucleotides of 39-noncoding sequence (8).
Regions that went through single-stranded intermediates or had been
amplified by polymerase chain reaction were sequenced to confirm the
absence of adventitious changes. A BamHI-MluI fragment containing
the mutated sequence was ligated with a 6943-nucleotide EcoRI-partial
BamHI fragment of the bovine M6P/IGF2R and a 7.2-kilobase EcoRI-
MluI fragment of the pSFFVneo expression vector (16) modified to
contain a 39-MluI site (8) to generate the final construct. The full-length
receptor chimera (referred to as the wild-type receptor) encodes the
bovine signal sequence (44 residues) and most of the bovine extracyto-
plasmic domain (2221 residues) followed by murine sequences (45 res-
idues of extracytoplasmic domain and complete transmembrane and
cytoplasmic domains).
Sorting Assay—The details of the sorting assay have been described
previously (8). For each experiment, the same passage of L(CIMPR2)D9
cells were thawed and transfected in parallel with the pSV2neo selec-
tion marker, wild-type bovine/murine M6P/IGF2R in pSFFVneo, and
different receptor mutants in pSFFVneo. Within 2 weeks after selection
with G418, for each construct, 32–48 colonies were isolated using clon-
ing cylinders and analyzed for receptor expression and homogeneity by
immunofluorescence. Select clones were assayed for secretion of phos-
phorylated lysosomal enzymes, total cellular protein, and receptor lev-
els. Representative clones were expanded and frozen for later use.
Surface Distribution Assay—Confluent cells in 24-well plates were
transferred to an ice-water bath and washed once with ice-cold PBS.
One set of duplicate wells were washed twice with DMEM/F-12 and
10% M6P/IGF2R-depleted FBS and then incubated with ;750 ng of
monoclonal antibody DM86f (a mixture of ;106 cpm iodinated antibody
and unlabeled antibody) in 0.3 ml of DMEM/F-12 and 10%M6P/IGF2R-
depleted FBS for 90 min. A second set of duplicate wells were treated
identically, except the wash and incubation solutions contained 0.3%
saponin. Cells were washed four times with PBS and 1% bovine serum
albumin and four times with PBS, solubilized with 0.5 ml of 0.1 N
NaOH, and counted in a g-counter. The radioactivity associated with
cells treated with and without 0.3% saponin represents total and cell-
surface receptor, respectively.
Internalization Assay—Short-term internalization of affinity-puri-
fied phosphorylated b-glucuronidase was conducted using a modifica-
tion of the procedure described (6). Confluent cells in 12-well plates
were transferred to an ice-water bath and sequentially washed once
with ice-cold PBS; once with DMEM/F-12, 5 mM mannose 6-phosphate,
and 10% M6P/IGF2R-depleted FBS; and twice with DMEM/F-12 and
10% M6P/IGF2R-depleted FBS. Cells were incubated with ;2.5 3 106
cpm 125I-labeled b-glucuronidase in 0.5 ml of ice-cold DMEM/F-12 and
10% M6P/IGF2R-depleted FBS for 60 min. The radioactive b-glucuron-
idase was removed, and cells were washed four times with ice-cold PBS
and 1% bovine serum albumin and six times with PBS. To initiate
endocytosis, plates were placed in a 37 °C water bath, and 0.5 ml of
37 °C DMEM/F-12 medium was added. At the indicated time points, the
medium was collected, and cell-surface b-glucuronidase was stripped
using 0.5 ml of mannose 6-phosphate/trypsin solution at pH 5 (6). After
5 min, 0.5 ml of DMEM/F-12 and 10% M6P/IGF2R-depleted FBS was
added, and the mixture was transferred to 1.2-ml polypropylene tubes
in 96-tube carrier racks. The supernatants were collected after 5 min of
centrifugation at 800 3 g. Cell pellets, stripped supernatants, and
media were counted in a g-counter. Data in Fig. 9 are plotted as
cell-associated radioactivity normalized to total counts (pellet 1
stripped supernatant 1 medium, averaged over all time points). Inter-
nalization rate constants were calculated using the 15-, 30-, 45-, and
60-s time points and are based on the amount of radioactivity internal-
ized over a given time interval, normalized to the average surface
counts at the beginning and end of the time interval.
RESULTS
Classification of Mutants
Mutant receptors were analyzed by evaluating their ability
to correct hypersecretion of phosphorylated lysosomal enzymes
from a mouse L cell line that lacks endogenous M6P/IGF2R as
described previously (8). For each mutant, 8–15 stable trans-
fectants were analyzed for receptor levels and secretion of
phosphorylated lysosomal enzymes. High concentrations of
mannose 6-phosphate were included in the culture medium to
prevent indirect targeting through the endocytic pathway. In
addition, control experiments were performed to verify that
FIG. 1. Parameters used for classification of mutant receptors. Left panel, positive controls from 10 independent transfection experiments
are shown. Each experiment is represented by a different symbol. Curve fitting was performed using a four-parameter logistic regression program
(Sigmaplot 3.0, Jandel Scientific). Right panel, secretion indices of negative control cell lines (open squares) and four positive control cell lines
containing the highest levels of receptor (open circles) are shown for each experiment. Mean 6 S.D. values are indicated by the solid and dotted
lines.
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even severely impaired mutants folded properly as ascertained
by their intracellular distribution and ability to bind ligand and
to function in endocytosis.
This study is based on analysis of .1000 clonal cell lines
generated over the course of 10 independent experiments. In
each experiment, up to eight different mutants were trans-
fected and analyzed in parallel along with positive (wild-type
receptor) and negative (selection marker alone) controls. Ex-
amination of the positive controls indicates that the secretion
index (24-h secretion of phosphorylated lysosomal enzymes
normalized to total cellular protein) decreases and plateaus
with increasing receptor expression (Fig. 1, left panel). As an
indication of the plateau value, we have selected, from each
experiment, the four clones that express the highest levels of
receptor. Comparison of the positive controls with all clones
expressing selection marker alone indicates that expression of
saturating levels of wild-type receptor decreases secretion of
lysosomal enzymes by a factor of 2 (Fig. 1, right panel).
To help classify the effect of different mutations, we devel-
oped a numerical index to compare the relative ability of a
given construct and the wild-type receptor to correct secretion
of lysosomal enzymes from the receptor-deficient cells. This
index, the sorting efficiency (E), is given by the expression Ex 5
(Sneo 2 Sx)/(Sneo 2 Swt), where Sneo denotes the average secre-
tion index of all negative control clones, Sx denotes the average
secretion index for a given construct of the four clones contain-
ing the highest receptor levels, and Swt denotes the grand
average secretion of the four positive control clones that con-
tain the highest level of receptor from each of the 10 experi-
ments. Using this index, the sorting efficiency of the normal
receptor determined in 10 independent experiments ranges
from 0.77 to 1.18 (1.00 6 0.12, mean 6 S.D.) (Table I). Initially,
we classified mutants with sorting efficiencies above 0.76 as
not significantly impaired (within 2 S.D. of the wild-type
mean), those with sorting efficiencies ranging from 0.64 to 0.76
as borderline-impaired (falling between 2 and 3 S.D. below the
mean), and those with sorting efficiencies below 0.64 as im-
paired. As these assignments utilize only a portion of the data
and can be influenced by individual clones that exhibit extreme
variation, we also inspected the individual scattergrams of
secretion index plotted against receptor levels to determine if
the mutant appeared significantly different from the corre-
sponding wild-type positive control.
The C-terminal Region Contains a Major Sorting
Determinant
To identify determinants on the cytoplasmic domain of the
M6P/IGF2R required for efficient intracellular sorting of lyso-
somal enzymes, we systematically mutated groups of conserved
residues to alanines (Fig. 2). Residues important for endocyto-
sis are known to impair sorting (5, 9), but were excluded from
this analysis as it is difficult to experimentally distinguish
direct from indirect effects, as discussed previously (8). Of the
37 alanine cluster mutations analyzed, 29 had little or no effect
on sorting efficiency (Table I), and inspection of the scatter-
grams was consistent with this conclusion (see below and data
not shown). (Scattergrams of all constructs analyzed in this
study are compiled in Ref. 15.)
We also classify AC13 as not significantly impaired, despite
its having a borderline sorting efficiency. For this mutant, at a
given receptor level, most of the clones function similarly to the
positive controls transfected and analyzed in parallel (Fig. 3,
top left panel). The apparently impaired sorting efficiency (E 5
0.71 6 0.72) can be attributed to high secretion from a single
clone, which, if dropped from the calculation, would yield E 5
1.07 6 0.07.
TABLE I
Sorting efficiencies of the wild-type receptor and mutants analyzed in this study
Construct Exp. Sorting efficiency Secretion index Receptor
10 3 units/mg ng/mg
Alanine cluster mutants
AC01 304 0.45 6 0.14 9.37 6 0.83 0.44 6 0.29
AC02 330 0.03 6 0.26 11.97 6 1.60 0.81 6 0.16
AC02 359 0.51 6 0.10 9.01 6 0.60 0.90 6 0.49
AC03 359 0.54 6 0.25 8.83 6 1.55 0.15 6 0.01
AC03 375 0.22 6 0.25 10.80 6 1.50 0.41 6 0.44
AC04 304 1.19 6 0.22 4.86 6 1.37 1.02 6 0.41
AC05 331 0.90 6 0.21 6.63 6 1.31 0.53 6 0.07
AC06 331 0.82 6 0.44 7.13 6 2.72 0.25 6 0.11
AC07 331 1.19 6 0.10 4.83 6 0.61 1.42 6 0.23
AC08 331 1.13 6 0.07 5.25 6 0.44 0.60 6 0.04
AC09 359 0.81 6 0.13 7.16 6 0.82 0.38 6 0.31
AC10 352 0.97 6 0.05 6.22 6 0.28 0.58 6 0.05
AC11 369 0.95 6 0.06 6.33 6 0.36 1.06 6 0.39
AC12 369 0.80 6 0.35 7.21 6 2.13 0.57 6 0.44
AC13 369 0.71 6 0.72 7.79 6 4.41 0.54 6 0.63
AC14 369 0.93 6 0.39 6.46 6 2.41 0.63 6 0.41
AC15 359 0.98 6 0.13 6.12 6 0.80 0.71 6 0.19
AC16 304 1.23 6 0.03 4.60 6 0.19 0.61 6 0.20
AC17 304 1.18 6 0.03 4.90 6 0.21 0.45 6 0.16
AC18 304 0.89 6 0.06 6.69 6 0.39 0.21 6 0.03
AC19 304 1.08 6 0.09 5.56 6 0.55 0.42 6 0.22
AC20 359 0.65 6 0.13 8.13 6 0.79 0.42 6 0.19
AC21 359 1.02 6 0.15 5.89 6 0.93 1.11 6 0.21
AC22 352 0.93 6 0.14 6.46 6 0.87 0.47 6 0.12
AC23 369 1.03 6 0.13 5.86 6 0.78 0.92 6 0.31
AC24 359 0.89 6 0.12 6.67 6 0.73 0.77 6 0.54
AC25 352 1.04 6 0.05 5.78 6 0.29 0.33 6 0.14
AC26 369 0.97 6 0.08 6.22 6 0.46 0.79 6 0.13
AC27 331 1.01 6 0.17 5.93 6 1.06 0.60 6 0.37
AC28 352 0.73 6 0.17 7.67 6 1.03 0.43 6 0.19
AC29 331 1.04 6 0.12 5.76 6 0.74 0.64 6 0.23
AC30 352 0.98 6 0.09 6.15 6 0.55 0.41 6 0.14
AC31 331 1.18 6 0.14 4.95 6 0.84 0.47 6 0.08
AC32 359 0.98 6 0.18 6.17 6 1.13 0.61 6 0.17
AC33 330 0.54 6 0.38 8.86 6 2.35 0.32 6 0.13
AC34 352 1.14 6 0.06 5.14 6 0.34 0.88 6 0.29
AC35 352 0.89 6 0.13 6.68 6 0.82 0.24 6 0.06
AC36 330 0.79 6 0.27 7.31 6 1.65 0.71 6 0.41
AC37 352 0.69 6 0.11 7.92 6 0.67 0.73 6 0.12
1KK2 3 AA 388 1.11 6 0.09 5.33 6 0.53 0.72 6 0.17
4RR5 3 AA 388 1.09 6 0.07 5.45 6 0.42 0.91 6 0.16
Deletion and insertion mutants
D13 343 0.25 6 0.13 10.60 6 0.79 0.84 6 0.16
D17 343 0.29 6 0.20 10.36 6 1.21 0.81 6 0.14
D2 388 0.53 6 0.20 8.88 6 1.23 0.81 6 0.28
D4 343 0.39 6 0.22 9.77 6 1.32 0.98 6 0.20
D53 343 0.40 6 0.14 9.69 6 0.84 0.85 6 0.05
D79(1LLHI) 388 0.44 6 0.17 9.42 6 1.05 0.99 6 0.44
LL(1AA)HI 388 0.86 6 0.26 6.86 6 1.58 0.96 6 0.27
LLHI(1A) 388 0.97 6 0.10 6.20 6 0.61 1.09 6 0.50
LLHI(1AAA) 388 0.61 6 0.07 8.41 6 0.40 0.44 6 0.20
Substitution mutants
L164I 369 1.03 6 0.44 5.82 6 2.72 0.59 6 0.36
L163I 375 0.88 6 0.14 6.78 6 0.89 0.84 6 0.49
L163V 375 0.72 6 0.06 7.75 6 0.36 1.05 6 0.01
D162N 386 0.73 6 0.09 7.69 6 0.53 0.58 6 0.37
D162E 386 0.96 6 0.22 6.28 6 1.36 0.44 6 0.15
E161D 386 1.23 6 0.10 4.64 6 0.61 0.35 6 0.21
E161Q 386 0.43 6 0.27 9.51 6 1.67 0.19 6 0.02
D160E 386 0.30 6 0.13 10.30 6 0.79 0.75 6 0.20
D160N 386 0.31 6 0.18 10.26 6 1.12 0.62 6 0.13
S159A 386 0.64 6 0.19 8.25 6 1.16 0.45 6 0.09
S159C 375 0.78 6 0.13 7.39 6 0.80 0.97 6 0.23
S159D 375 1.15 6 0.13 5.08 6 0.80 1.07 6 0.21
S159E 375 0.99 6 0.07 6.07 6 0.40 1.59 6 0.24
S159T 375 0.89 6 0.13 6.67 6 0.81 1.16 6 0.25
D158E 386 1.20 6 0.11 4.81 6 0.70 0.68 6 0.31
D158N 375 1.03 6 0.04 5.86 6 0.25 1.23 6 0.25
D157E 386 1.13 6 0.06 5.25 6 0.39 0.51 6 0.14
D157N 375 0.92 6 0.17 6.52 6 1.03 1.32 6 0.30
Wild-type receptor
WT 304 1.18 6 0.18 4.89 6 1.08 0.33 6 0.16
WT 330 0.77 6 0.16 7.40 6 0.98 0.60 6 0.26
WT 331 0.90 6 0.08 6.66 6 0.46 0.32 6 0.16
WT 343 1.05 6 0.28 5.73 6 1.74 0.45 6 0.09
WT 352 0.96 6 0.26 6.25 6 1.58 0.40 6 0.13
WT 359 1.11 6 0.12 5.36 6 0.73 0.57 6 0.25
WT 369 1.03 6 0.18 5.81 6 1.09 0.74 6 0.25
WT 375 0.93 6 0.25 6.46 6 1.51 0.72 6 0.18
WT 386 0.94 6 0.09 6.39 6 0.55 0.41 6 0.03
WT 388 1.13 6 0.13 5.25 6 0.82 0.67 6 0.18
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The classification of AC33 as borderline-impaired is tenta-
tive. The impaired sorting efficiency index (E 5 0.54 6 0.38)
can be partially ascribed to a paucity of clones that express
relatively high levels of receptor, and at a given steady-state
level of receptor, the majority of the AC33 clones function
similarly to the corresponding wild-type controls (Fig. 3,mid-
dle right panel). At present, we cannot tell if the low level of
expression was idiosyncratic to this experiment or represents
a significant trend. However, it is worth noting that the AC33
mutation eliminates a pair of conserved cysteine residues
that are likely to be palmitoylated (17), and mutation of a
palmitoylated cysteine in the 67-residue cytoplasmic domain
of the cation-dependent mannose 6-phosphate receptor de-
creases the half-life and impairs the function of this receptor
(18, 19). While it is clear that the AC33 construct can par-
tially correct secretion of lysosomal enzymes, further study is
required to determine the functional significance of this
region.
Three additional mutants are classified as borderline-im-
paired (AC20, E 5 0.65 6 0.13; AC28, E 5 0.73 6 0.17; and
AC37, E 5 0.69 6 0.11). This assignment is supported by
inspection of the scattergrams (Fig. 3): while increased expres-
sion of each construct partially corrects secretion of lysosomal
enzymes, most clones exhibit higher secretion compared with
clones containing similar levels of wild-type receptor. The
AC20 mutation changes 74LSS76 to alanine; the AC28 mutation
changes 40TEWL43 to alanine. These regions have not yet been
further dissected to determine which side chains are important
for sorting. The AC37 mutation eliminates four positive
charges in the juxtamembrane region of the cytoplasmic do-
main (1KKERR5 changed to 1AAEAA5). To investigate this
region further, we analyzed two mutants in which either two
lysines or two arginines in this region were replaced with
alanines. Neither mutant was markedly different compared
with the normal receptor (Fig. 3 (bottom right panel) and Table
I). It is noteworthy that these residues are part of a consensus
stop transfer sequence found on many other membrane pro-
teins (20). Thus, the positively charged cluster may be impor-
tant for correct positioning of the cytoplasmic domain with
respect to the membrane rather than being part of the sorting
signal per se.
Three impaired mutants encompass the last 12 amino acids
of the 166-residue cytoplasmic domain (AC01, AC02, and
AC03) (Fig. 4). AC01 and AC02 are clearly impaired as judged
from their sorting efficiencies and inspection of the scatter-
grams. For AC03, in the course of five independent transfection
experiments using two different constructs encoding the same
amino acid changes, almost all clones isolated contained low
levels of receptor. The two experiments shown (Fig. 4 (bottom
left panel) and Table I) represent the highest receptor levels
found, and here, the individual clones containing medium (0.28
ng/mg) and high (1.06 ng/mg, plotted on the right axis) levels of
receptor are impaired.
These findings are in good agreement with our previous
findings (8), where alanine scanning of the C-terminal 14 res-
idues revealed that the consensus casein kinase II site followed
by two leucines (157DDSDEDLL164) is important. A second
sequence that contains a consensus casein kinase II site fol-
lowed by two hydrophobic residues (80DDQDSEDEVL89) occurs
in the middle of the cytoplasmic domain, and both casein ki-
nase II sites are phosphorylated in vivo (21–23). However, this
internal sequence is not required for efficient lysosomal en-
zyme sorting as the three alanine cluster mutants that span
residues 80–91 are all indistinguishable from the wild-type
receptor (Fig. 4, bottom right panel). Taken together, these
results indicate that most of the cytoplasmic domain is replace-
able, and with the possible exception of the tyrosine-based
FIG. 2. Sorting function of the alanine cluster mutants. Resi-
dues of the mouse M6P/IGF2R cytoplasmic domain are upper-case if
they are identical or conserved in the mouse, cow, and human se-
quences (8). Residues important for endocytosis are in boldface; casein
kinase II sites are underlined. The identity of each alanine cluster
mutant and its function in sorting relative to the wild-type receptor are
shown below the sequence. Classification of mutants is described under
“Results.” Open circles, not significantly impaired; shaded circles, bor-
derline-impaired; closed circles, impaired.
FIG. 3. Effect of alanine cluster mutations on sorting. The func-
tion of L(CIMPR2)D9 cells expressing a given mutant (closed circles) is
compared with that of cells expressing the wild-type receptor (open
circles), with each panel depicting cells that were transfected and ana-
lyzed in parallel. The solid curve represents the best fit value for all
positive controls (see Fig. 1, left panel); the upper and lower dotted
reference lines represent the average secretion indices of all negative
and select positive controls (see Fig. 1, right panel). For clarity of
presentation, clones with secretion indices .13 or receptor levels .1
are plotted on the upper and right axes, respectively. In the bottom right
panel, closed circles and plus signs represent the 1KK23 AA and 4RR5
3 AA mutations, respectively.
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internalization signal, the C-terminal region of the receptor
contains the major determinant for lysosomal enzyme sorting.
Positional Effects on the C-terminal Sorting Signal
To further investigate the C-terminal sorting signal, we cre-
ated a series of deletion and insertion mutants. In our previous
study (8), alanine substitution of either His-165 or Ile-166 had
no effect on receptor function, while mutations of upstream
residues had marked effects. Interestingly, deletion of the C-
terminal two residues clearly impaired receptor function (E 5
0.53 6 0.20) (Fig. 5, top right panel). The sorting efficiency of
this mutant was only slightly higher than that of constructs
containing deletions of the C-terminal 4, 13, 17, or 53 residues
(representative scattergrams in Fig. 5 (top left panel) and Table
I). The C terminus was extended by insertion of two alanines
between Leu-164 and His-165 (construct LL(1AA)HI). Despite
the nearly normal sorting efficiency (E 5 0.86 6 0.26), this
mutation may have a modest effect on receptor function in
sorting: while two clones containing high levels (1.01 and 1.36
ng/mg) appear normal, most clones had higher secretion indices
than clones containing equivalent levels of the wild-type recep-
tor (Fig. 5, bottom left panel). Addition of three alanines to the
C terminus clearly impaired sorting (LLHI(1AAA), E 5 0.61 6
0.07), while addition of one alanine had little effect (LLHI(1A),
E 5 0.97 6 0.10) (Fig. 5, bottom right panel). These results
suggest that the precise distance of the C-terminal carboxylate
from the sorting signal is not critical; rather, downstream
residues are important for proper presentation of the
determinant.
Given the similarity between the two casein kinase II sites of
the receptor, it is possible that if presented in a different
context, the internal casein kinase II site could be converted
into a functional sorting signal. To test this hypothesis, we
deleted an internal fragment of the cytoplasmic domain (resi-
dues 88–162) to produce the mutant D79(1LLHI), which had
the C-terminal sequence 80DDQDSEDELLHI91. This mutant
was clearly impaired in sorting (Fig. 5, top right panel), indi-
cating that either spacing or other specific features of the
normal C-terminal signal (see below) are required for efficient
function in sorting.
Dissection of the C-terminal Sorting Signal
The major sorting determinant of the M6P/IGF2R contains
two features of potential functional significance. First, the re-
gion contains two adjacent leucines, and dileucine motifs are
putative signals for intracellular trafficking of proteins. Sec-
ond, the serine and surrounding acidic cluster form an almost
perfect consensus casein kinase II site (24), which has been
shown to be phosphorylated in vivo (21–23). To dissect the key
features of this region, we conducted a high resolution mu-
tagenesis analysis of these residues. The results of this analy-
sis, combined with our previous data, are summarized in Fig. 6.
Dileucine Motif—In our previous study (8), we found that
alanine substitution of either Leu-163 or Leu-164 had marked
effects on sorting. To further investigate their role, we replaced
each residue with valine and isoleucine. Only low expressing
clones were isolated for the L164V mutant, precluding evalu-
ation of this substitution (data not shown). The L163V mutant
had a borderline sorting efficiency (E 5 0.72 6 0.06) and
appeared impaired relative to the normal receptor (Fig. 7, top
left panel). In contrast, the two isoleucine replacement mutants
appeared to function normally (Fig. 7, top panels). Taken to-
gether with the alanine scanning mutants, these data stress
the importance of large aliphatic side chains at these two
positions.
Casein Kinase II Site—We previously found that replacing
Ser-159 with alanine impairs sorting (8). In contrast, Johnson
and Kornfeld (9) analyzed a single clone that expressed a
FIG. 4. Effect of alanine cluster mu-
tations that encompass the two ca-
sein kinase II sites. Data are plotted as
described in the legend to Fig. 3. Top right
panel, circles represent data from Exper-
iment 330, and squares represent data
from Experiment 359. Bottom left panel,
circles represent data from Experiment
359, and squares represent data from Ex-
periment 375. Bottom right panel, closed
circles are AC16, plus signs are AC17, and
closed triangles are AC18.
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mutant bovine receptor with multiple alanine substitutions at
potential kinase sites (murine numbering, S19A, T40A, S84A,
and S159A) and found that it functioned normally in terms of
targeting cathepsin D. To recheck our findings, we confirmed
the cytoplasmic domain sequence of the S159A mutant and
conducted an independent transfection experiment to assess its
function in sorting. These results corroborate our original ob-
servations, verifying that in our system, the receptor does not
readily tolerate alanine substitution at position 159 (Table I
and data not shown).
To examine the role of Ser-159 in sorting, we replaced this
residue with threonine, cysteine, glutamate, or aspartate. None
of the mutations had major effects on sorting (Fig. 7 (bottom
panels) and Table I). However, from the sorting efficiencies and
inspection of the individual scattergrams, it appears that the
S159D mutant may be marginally more efficient than the nor-
mal receptor, and the S159C mutant may be slightly impaired.
Taken together with the alanine scan, these results indicate
that a polar side chain at position 159 is important, but show
that cycles of serine phosphorylation/dephosphorylation are
not obligatory for intracellular trafficking of the M6P/IGF2R.
We previously found from alanine scanning mutagenesis
that each of the five charged residues flanking Ser-159 was
important for efficient sorting (8). To determine if charge or
shape was important, we examined the effects of isoelectric and
isosteric substitutions. Four residues readily tolerated conserv-
ative substitutions: mutants with isoelectric substitutions at
Asp-157 (D157E), Asp-158 (D158E), Glu-161 (E161D), and Asp-
162 (D162E) all functioned at least as efficiently as the wild-
type receptor (Fig. 8 and Table I). Isosteric substitutions at
some of these residues were relatively innocuous, with the
D162N, D158N, and D157N mutants functioning similarly to
the wild-type receptor (Fig. 8 and Table I; also data not shown).
The E161Q construct had a low sorting efficiency (E 5 0.43 6
0.27). While this may have been a result of the general low
expression, comparison of E161Q clones containing similar lev-
els of receptor with both the E161Dmutant and positive control
suggests that the isosteric mutation is not well tolerated (Fig.
8, bottom left panel). Asp-160 was unique in that isoelectric and
isosteric substitutions severely impaired function (D160E, E 5
0.30 6 0.13; and D160N, E 5 0.31 6 0.18) (Fig. 8, top right
panel), indicating that this residue is a critical component of
the sorting signal.
FIG. 5. Effect of deletion and inser-
tion mutations. Data are plotted as de-
scribed in the legend to Fig. 3. Top left
panel: closed circles, D4; plus signs; D53.
Top right panel: closed circles, D2; plus
signs, D79(1LLHI). Bottom right panel:
closed circles, LLHI(1A); plus signs,
LLHI(1AAA).
FIG. 6. Summary of the mutational analysis of the C-terminal
sorting signal. The calculated sorting efficiencies of the mutants an-
alyzed in this study are taken from Table I. The solid and dotted
reference lines mark the mean 6 2 S.D. for the wild-type receptor.
Sorting efficiencies of the alanine scanning mutants analyzed in our
previous study (8) were calculated using the positive and negative
controls for that data set.
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Sorting Mutants Have Normal Endocytic Efficiency and
Surface Distributions
One concern is that mutations potentially could increase the
rate at which the receptor traveled to the plasma membrane or
decrease the rate of internalization. This could result in deple-
tion of the intracellular pool of the receptor and thus indirectly
interfere with sorting. In the course of selecting clonal cell lines
for this study, all clones were first screened by immunofluores-
cence to estimate relative receptor expression and to evaluate
clonal homogeneity as described previously (8). No marked
differences in cellular distribution were evident. As an addi-
tional quantitative test, we measured the surface distribution
of one or two clones for all constructs analyzed in this study.
Here, intact and saponin-permeabilized cells were probed with
125I-labeled anti-M6P/IGF2R monoclonal antibody to estimate
cell-surface and total receptor, respectively. For the wild-type
receptor, 91–96% was intracellular as determined by analysis
of six different clones. Control experiments revealed that a
truncated bovine M6P/IGF2R with a seven-residue-long cyto-
plasmic domain that lacks the tyrosine internalization signal
(cell line Dd4 (5)) accumulated on the cell surface, with only
44% being intracellular. In contrast, all the mutants described
in this and our previous (8) studies were at least 85% intracel-
lular (compiled in Ref. 15; data not shown). This indicates that
the intracellular pool of the receptor was not sufficiently de-
pleted to interfere with sorting.
We also measured the endocytic efficiency of a number of the
highly impaired sorting mutants. These experiments were car-
ried out essentially as described (6). Briefly, cells were placed
on ice to arrest endocytosis, incubated with 125I-labeled b-glu-
curonidase at 4 °C for 1 h, washed, and rapidly warmed to
37 °C, and the radioactivity released into the medium, bound to
the surface, and internalized was measured at different time
intervals. The normal receptor internalized ligand rapidly,
with a half-time of ;1 min (Fig. 9, top left panel). In contrast,
the control Dd4 cell line was markedly impaired (Fig. 9, bottom
right panel). For all other mutants analyzed, the significant
finding was that while minor differences may be present, they
internalized ligand at rates comparable to the normal receptor
(see Fig. 9 and legend). Thus, these severely impaired sorting
mutants fold properly as demonstrated by their ability to bind
and rapidly internalize ligand.
DISCUSSION
One noteworthy finding of this study is that apart from the
endocytosis signal, a single contiguous stretch of eight residues
near the C terminus is the sole major sorting determinant
revealed by our assay. While part of the cytoplasmic domain
may be structural, additional determinants may be important
for other processes such as proper trafficking in polarized cells
(25, 26) or insulin-stimulated redistribution to the cell surface
in adipocytes (27). In addition, it is possible that regions out-
side the C-terminal region not detected in our assay contribute
to sorting. For instance, if the concentration of sorting compo-
nents and their affinity for the receptor cytoplasmic domain are
sufficiently high, then mutations that cause modest changes in
affinity may not be apparent. This could be exacerbated if the
host cell line has up-regulated other components of the sorting
system in an attempt to compensate for impaired lysosomal
transport. Nonetheless, our results clearly demonstrate that
the C-terminal region is of paramount importance for sorting.
The C-terminal region of the receptor contains two recogniz-
able sequence elements, a dileucine motif and a consensus
casein kinase II site. As summarized in Fig. 6, this and our
previous (8) studies demonstrate that both elements are in-
volved in sorting. At present, we cannot distinguish whether
FIG. 7. Effect of mutations on the
dileucine motif and Ser-159. Data are
plotted as described in the legend to Fig.
3. Top left panel: closed circles, L163I;
plus signs, L163V. Bottom left panel:
closed circles, S159D; plus signs, S159E.
Bottom right panel: closed circles, S159T;
plus signs, S159C.
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both or one of these elements is involved in either departure
from the trans-Golgi network to endosomes or transit from
endosomes to the trans-Golgi network. However, recent studies
on the cation-dependent mannose 6-phosphate receptor, which
also has a consensus casein kinase II site and dileucine motif
near the C terminus (EESEERDDHLLPM), suggest that these
motifs may have independent functions: mutations in either
motif alone resulted in impaired sorting, while only mutations
in the consensus casein kinase II site impaired binding of the
Golgi adaptor AP1 in an in vitro assay (28).
Dileucine Motif
Dileucine motifs are thought to participate in a wide range of
targeting steps. This sequence was first noted as a semi-auton-
omous targeting element on the cytoplasmic domain of the CD3
g- or e-subunit that could direct a Tac antigen chimera to the
lysosome (29). Depending on the presence or absence of an
intact tyrosine signal, this determinant could mediate direct
(Golgi to lysosome) or indirect (Golgi to surface to lysosome)
targeting. Subsequently, dileucine or dihydrophobic motifs
have been implicated in trafficking events including lysosomal
targeting of lysosomal integral membrane protein II (30, 31),
endocytosis and basolateral sorting of macrophage IgG Fc re-
ceptors (32, 33), trafficking of the Glut4 glucose transporter
(34–36), rapid internalization of the major histocompatibility
complex invariant chain (37), internalization of the insulin
receptor (38), protein kinase C-dependent down-regulation of
the T cell receptor (39), as well as intracellular trafficking of
both types of mannose 6-phosphate receptors (8, 9, 28, 40).
While in some of these cases perturbations of adjacent hydro-
phobic residues may have indirect effects on another functional
element, experiments with reporter molecules support the no-
tion that the dileucine-based determinants represent traffick-
ing signals.
The information content of dileucine or dihydrophobic motifs
seems rather low, as given their relatively high abundance,
they are commonly found in the cytoplasmic regions of many
transmembrane proteins. (From analyzing sequences in the
SwissProt data base (Version 14), the frequency of finding two
adjacent residues being leucine is 0.9%; being leucine or iso-
leucine, 2.3%; and being leucine, isoleucine, or valine, 4.7%.
The probability (p) of a random sequence of n residues contain-
ing one or more pairs of adjacent residues with a given abun-
dance (f) is p 5 1 2 (1 2 f)n21. Thus, for a 100-residue sequence,
the probability of having adjacent leucines or isoleucines is
;90%.) The wide variety of sequences that function in reporter
constructs suggests that if these elements are recognized by a
common binding site, the requirements for molecular recogni-
tion are rather loose. In this respect, dileucine motifs resemble
tyrosine motifs, where a wide variety of related sequences can
direct internalization from the plasma membrane, albeit at
vastly different rates (41).
One intriguing possibility is that dileucine motifs evolved
from a quality control pathway that serves to target damaged
membrane proteins to the lysosome. In this case, protein dam-
age would cause the normally inaccessible dihydrophobic de-
terminant to be exposed at the surface of the molecule. If there
were no downstream retrieval event, this pathway could func-
tion with relatively slow kinetics, as the targeting step would
be essentially irreversible. Relatively inefficient signals may
also suffice for delivery of resident membrane proteins to lyso-
somes. At the other end of the spectrum, receptors such as the
M6P/IGF2R whose function requires rapid recycling between
different compartments may require more efficient signals, and
the recognition determinant may be more extensive. It will be
important to identify the cellular components that recognize
these motifs and to investigate their role in both trafficking and
protein turnover.
FIG. 8. Effect of isosteric and iso-
electric substitutions at acidic resi-
dues within the C-terminal casein ki-
nase II site. Data are plotted as
described in the legend to Fig. 3. Top left
panel: closed circles, D157E; plus signs;
D158E. Top right panel: closed circles,
D160N; plus signs, D160E. Bottom left
panel: closed circles, E161Q; plus signs,
E161D. Bottom right panel: closed circles,
D162N; plus signs, D162E.
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Consensus Casein Kinase II Site
Serine Phosphorylation Is Not Essential for Function—Stud-
ies by Hoflack and co-workers (21, 22) suggest that phospho-
rylation of the casein kinase II sites in the cytoplasmic domain
may be involved in receptor trafficking. In experiments per-
formed on normal rat kidney cells, both Ser-159 and Ser-84
underwent cycles of phosphorylation/dephosphorylation, and
phosphorylation occurred either in the trans-Golgi network or
shortly after exit. Interestingly, while the distribution of the
data obtained from our experimental system precludes firm
conclusions regarding minor functional differences, close in-
spection of the data suggests that the rank order for intrinsic
sorting efficiency may be S159A , S159C , S159T ; wild-
type ; S159E , S159D (Figs. 6 and 7). As aspartate can mimic
phosphoserine in poly-Ig receptor trafficking (42), and threo-
nine can serve as a substrate for casein kinase II (24), it is
possible that phosphorylation may increase the affinity of the
receptor for cellular components that effect trafficking. This
would be consistent with in vitro binding studies (43). However,
an important finding is that in our experimental system, cycles
of phosphorylation/dephosphorylation clearly are not obliga-
tory for receptor function in sorting.
The Acidic Cluster and Aspartate 160 Are Critical Compo-
nents of the Sorting Signal—From the analysis of Ser-159 and
the surrounding residues, we conclude that the acidic cluster,
rather than the serine itself, is the most critical feature of the
consensus casein kinase II site. Interestingly, acidic clusters
have been noted to occur on the cytoplasmic domains of other
cycling proteins (44). Recently, acidic clusters in the cytoplas-
mic domain of furin (45–48) and invariant chain (49) have been
implicated in intracellular trafficking events. The acidic clus-
ters may be important for protein-protein interactions, either
through direct contact or by coordinating a divalent cation.
Alternatively, the aspartate may have some key catalytic role
or may be transiently modified, as found in the bacterial two-
component system (50). It will be interesting to determine if
key aspartates are also critical for the intracellular trafficking
functions of other proteins and, if so, to further dissect their
role in the trafficking process.
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